12:00 AM
 | 
Aug 03, 2015
 |  BioCentury  |  Finance

General trickle

Why one ETF manager thinks biotech has room to run

Although biotech indices have advanced at least 2% this quarter and are frequently touching new highs, Paul Yook of LifeSci Capital expects the sector has more room to run. The reason, he said, is generalist investors have not entered biotech en masse.

"Generalists are not involved in biotech in a huge way. Thus, I don't really believe we're near a top," Yook told BioCentury.

Yook said the generalists he's meeting with are interested in initially putting about 0.5%...

Read the full 384 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >